The Journal of mHealth Vol 1 Issue 1 (Feb 2014) - Page 27

with Aventyn’s Vitalbeat chronic disease management ecosystem, this web-based solution will enable hospitals, physician offices, university medical centres, home care providers, hospices and clinical researchers to remotely monitor patient physical activity and capture relevant changes in activities of daily living. The patented PAMSys technology is based on over 10 years of research supported in part by the National Institutes of Health. PAMSys is a lightweight, wearable motion sensor that uses advanced signal processing algorithms and novel biomechanical models of human motion to monitor body position, evaluate walking patterns, automatically detect falls, and assess sit-to-stand and stand-to-sit postural transitions. Vitalbeat™ is a simple, cost effective remote patient monitoring and integrated chronic disease management system for managing long term conditions. With Vitalbeat and advanced telehealth sensors like PAMSys, clinicians remotely monitor patient vital signs and activity levels securely using smartphones and tablet computers, and design long term disease management programs for co-morbidities associated with heart failure, diabetes, obesity, and many other conditions. Patients manage diet, physical activity, and medication compliance by configurable alerts and reminders based on personalised thresholds, goals and clinical requirements. Patient electronic health record data integrates with Vitalbeat along with social networking sites like Twitter and Facebook to provide care continuity, group sharing and networking with clinicians, family and like-minded friends. ton, D.C., Eric Dishman, Intel Fellow and general manager of Intel’s Health & Life Sciences Group, reiterated Intel’s belief that next generation technology for continuous monitoring of patient vital signs, such as ViSi® Mobile by Sotera® Wireless shown live during the keynote, could transform the delivery of care and benefit health outcomes, patient satisfaction, and healthcare costs. PAMSys™ with Vitalbeat™ is selectively available for clinical research and commercial deployment by healthcare providers and payers. The two companies plan to provide remote patient monitoring solutions and subscription services for a variety of disease conditions to be billed under existing CPT codes for ambulatory electrocardiographic monitoring, education and patient self-management, and fall risk assessment, as well as new CPT codes based on clinical outcomes from ongoing and future clinical trials. “A great example of mobile technology that holds promise to improve patient safety and the whole experience of being a high-risk patient is continuous monitoring of vital signs in the hospital,” said Dishman. “Rather than inconvenient manual spot checks that yield intermittent data, this mobile technology makes it possible for the first time to monitor all vital signs continuously through a small, wearable device that transmits data wirelessly.” VISI MOBILE PRESENTED DURING ERIC DISHMAN’S MHEALTH SUMMIT KEYNOTE ADDRESS Following his keynote address at the mHealth Summit in Washing- A finalist for CONNECT’s 2013 “Most Innovative Product” Award, the ViSi Mobile System packs powerful patient monitoring capabilities into a 4 ounce wrist-worn device ensuring clinicians anytime, anywhere access to accurate and trended vital sign information. With the recent addition of continuous, cuffless nonContinued on page 26 25 The Journal of mHealth